Abstract: The present disclosure relates to the in vivo prevention or treatment of hematologic malignancy relapse using a TNFR2 antagonist (an anti TNFR2 antagonist antibody) (i) for use in the prevention or treatment of hematologic malignancy relapse after allogeneic hematopoietic stem cell transplantation (AHCT) or after a treatment with lymphocytes and (ii) for use in enhancing the graft-versus-leukemia-activity (GVL activity) of a hematopoietic stem cell transplantation (HCT) or a treatment with lymphocytes.

Abstract: Method of determining configuration of interferential filtering elements for an optical device having an optical substrate for a user, includes: providing a first set of parameters representative of at least one main line of sight of the user; determining a first selected range of angles of incidence based on the first parameters; providing a second set of parameters characterizing, for the user, a range of wavelengths to be at least partially inhibited; determining a first selected range of wavelengths of incident light to be at least partially inhibited, based on the second parameters; and configuring a first selective interferential filtering element and a first zone of a surface of the optical substrate based on the first selected range of angles of incidence and wavelengths such that the first selective interferential filtering elements inhibit, at a first rate of rejection, transmission of the first selected range of wavelengths of incident light.

Abstract: Chemical compounds and the therapeutic use thereof, in particular for improving muscular quality in mammals. More particularly, a method of improving muscular quality in sarcopenic mammals and treating and/or preventing sarcopenia using the chemical compounds and, in particular, sarcopenic obesity and the associated complications and/or pathologies thereof, such as loss of strength, muscle mass, performance and of physical and movement capacity. Also, a method of improving muscle quality in obese mammals and treating and/or preventing of obesity and associated complications and/or pathologies, advantageously type 2 diabetes and metabolic syndrome, using the chemical compounds.

Abstract: Some embodiments are directed to a method and a system allowing moving tags to be discriminated from stationary tags, which can be used in the field of tracking merchandise or objects provided with RFID tags.

Abstract: A device for switching an electrical signal, controlled by an optical wave and having an on state and an off state, which can be inserted into a microwave transmission line, comprises a semiconductor substrate on which two conductive tracks are formed, these tracks being separated by a gap providing electrical insulation between the two tracks and each being connected to an input port and an output port, in the on state the electrical contact between the two tracks being established by illuminating the substrate in the region of the gap by means of the optical wave, the input impedance and the output impedance of said switching device being mismatched to the impedance of the transmission line in the off state and are matched to the impedance of the transmission line in the on state.

Abstract: An optical device including an optical substrate including a first surface having a first zone provided with first selective interferential filtering element for selectively inhibiting transmission of incident light based on the wavelength spectrum of the incident light, the first selective interferential filtering being configured to inhibit, at a first rate of rejection, transmission of a first selected range of wavelengths of incident light, incident on the first zone within a first selected range of angles of incidence, wherein the first selected range of angles of incidence is determined based on at least one main line of sight of a user.

Abstract: Method of determining configuration of interferential filtering elements for an optical device having an optical substrate for a user, includes: providing a first set of parameters representative of at least one main line of sight of the user; determining a first selected range of angles of incidence based on the first parameters; providing a second set of parameters characterizing, for the user, a range of wavelengths to be at least partially inhibited; determining a first selected range of wavelengths of incident light to be at least partially inhibited, based on the second parameters; and configuring a first selective interferential filtering element and a first zone of a surface of the optical substrate based on the first selected range of angles of incidence and wavelengths such that the first selective interferential filtering elements inhibit, at a first rate of rejection, transmission of the first selected range of wavelengths of incident light.

Abstract: An optical device including: an optical substrate provided with selective optical filtering element configured to selectively inhibit transmission, through the optical substrate of at least one selected range of wavelengths of incident light in the visible light spectrum at an inhibition rate of at least 5%, the selective optical filtering element being further configured to transmit at least 8% of incident light of the visible spectrum outside the at least one selected range of wavelengths; wherein the at least one selected range of wavelengths has a bandwidth in a range of from 10 nm to 70 nm, preferably 10 nm to 60 nm centered on a wavelength within a range of between 430 nm and 465 nm.

Abstract: The present invention relates to novel synthetic or natural peptides for use in treating viral or parasitic infections or in the treatment of tumors. The peptides of the present invention are less than 30 amino acids in size, preferably less than 20 amino acids, in particular 15 to 20 amino acids, and in vitro the peptides specifically bind a type 2A protein phosphatase holoenzyme or one of its subunits. The invention also relates to a method for identifying said peptides, and to their uses.

Abstract: The invention relates to a structure comprising: at least one mesostructured layer, prepared by a sol/gel method from at least one specific metallic molecular precursor in the presence of a specific texturing agent and a metal substrate. The invention further relates to the method for production and use thereof in aeronautics and aerospace.

Abstract: The present invention relates to a structure comprising: at least one mesostructured layer prepared by the sol-gel route from at least one specific molecular metallic precursor in the presence of an amphiphilic surfactant, and a metal substrate. It also relates to its process of preparation and to its use in the aeronautical or aerospace field.

Abstract: The present invention relates to the use of a nanostructured material, as a protective coating for metallic surfaces, said nanostructured material comprising functionalized nano-building blocks and a polymer or hybrid organic/inorganic matrix. It also relates to a particular nanostructured material in which the matrix is prepared from at least three silicon alkoxides.